Global elimination of hepatitis C virus by 2030: The pessimistic view

Thomas G. Cotter, Michael Charlton

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

While Hepatitis C virus (HCV) infection meets criteria for elimination, current screening strategies globally are inadequate and resource allocation for screening and treatment is largely inadequate, particularly in resource-constrained countries. The observed effectiveness of direct-acting antiviral therapy has raised the theoretical possibility of HCV elimination. One indicator of the likelihood of achieving HCV elimination is the effectiveness of current screening and treatment recommendations and policies. Considering the absence of an effective vaccine, the most critical tool in the elimination of smallpox infection, the primary prevention of HCV transmission is as important as treating those already infected in any HCV elimination strategy. The effect of prevention interventions on incidence of HCV infection is primarily dependent on local epidemiology. Restricting treatment to only those with advanced fibrosis ignores the morbidity associated with chronic infection, including fatigue, and the extrahepatic complications, such as lymphoma.

Original languageEnglish (US)
Title of host publicationClinical Dilemmas in Viral Liver Disease, Second Edition
Publisherwiley
Pages244-249
Number of pages6
ISBN (Electronic)9781119533481
ISBN (Print)9781119533399
DOIs
StatePublished - Jan 1 2020
Externally publishedYes

Keywords

  • direct-acting antiviral therapy
  • fibrosis
  • hepatitis V virus
  • lymphoma
  • smallpox infection

ASJC Scopus subject areas

  • General Medicine

Fingerprint

Dive into the research topics of 'Global elimination of hepatitis C virus by 2030: The pessimistic view'. Together they form a unique fingerprint.

Cite this